Women In Medtech Archives - Page 2 of 3

How this inside-out vascular access system simplifies catheter placement

Gabi Niederauer is president and CEO of Bluegrass Vascular Technologies. [Image courtesy of Bluegrass Vascular Technologies]

Bluegrass Vascular Technologies is making catheter placement procedures for dialysis and chemotherapy easier and safer using inside-out technology, explains CEO and President Gabi Niederauer.

Bluegrass Vascular Technologies has figured out a way to make a catheter sheath go inside the body and back out for easy catheter placement in standard access procedures.

The San Antonio, Texas–based company’s Surfacer Inside-Out access system facilitates catheter insertion into the central venous system. The company designed it for use in patients with upper body venous occlusions or other conditions that preclude central venous access by conventional methods.

One of the challenges of having a catheter in the body for weeks or months for dialysis or chemotherapy is the risk of blood…

What’s next for Jennifer Fried after leaving Explorer Surgical?

Jennifer Fried is the co-founder of Explorer Surgical [Photo courtesy of Explorer Surgical]

Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October.

Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter.

“It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown by since my first day in the OR almost nine years ago! I am sad to leave our incredible team and customers, but I know that our company is in good hands for its next phase of growth.”

Fried’s last day as Chicago-based Explorer Surgical’s GM was June 30. Ryan Padilla is the new business line leader, Fried said in an interview with Medical Design & Outsourcing.

“He has been a part of …

Levita Magnetics raises $26M for Magnetic-Assisted Robotic Surgery platform

Levita’s Magnetic-Assisted Robotic Surgery (MARS) platform [Photo courtesy of Levita]Levita Magnetics said today it has raised $26 million to fund regulatory and commercial progress on its Magnetic-Assisted Robotic Surgery (MARS) platform.

The Menlo Park, California-based robotic surgery system developer also appointed Maria Sainz as chair of its board of directors.

The MARS platform is designed to help surgeons perform more high-volume abdominal procedures using fewer incisions and fewer personnel.

Levita won FDA de novo classification for its Levita Magnetic Surgical System in 2015. That handheld device uses a magnet placed outside of a patient’s abdomen to control a magnetic grasper inside the body during surgery, requiring only one incision instead of two.

The device requires someone to hold the external magnet while the surgeon is operating, but the new MARS platform assists with the external magnet and gives the surgeon more control…

ResMed names Lucile Blaise as new Sleep & Respiratory Care leader

Lucile Blaise will become president of ResMed’s Sleep & Respiratory Care business on July 1. [Photo courtesy of ResMed]Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today.

She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during the transition.

Blaise is ResMed’s VP of Sleep & Respiratory Care for Western Europe. She joined San Diego-based ResMed in 2006 and has more than 25 years of experience in medical device sales, marketing, finance, and business development, the company said in a news release.

Get the full story at our sister site, Medical Design & Outsourcing.

MDO wins honors from American Society of Business Publication Editors

Judges reviewed the March and May 2021 editions of Medical Design & Outsourcing before awarding the publication with a design award. [Cover designs by Matt Claney/MDO]

Medical Design & Outsourcing received awards for design and content at the American Society of Business Publication Editors’ 2022 Azbee Awards of Excellence yesterday.

The annual awards program honors outstanding work by U.S.-based business-to-business, trade, association and professional publications, including magazines, websites, email newsletters, social media and blogs. The organization calls its awards program “one of the most competitive” in publishing.

Art Director Matt Claney won a regional silver award for magazine design and was a national finalist. Judges considered the March 2021 and May 2021 editions of MDO.

“MDO showcases the ability to cover everything from hot topics such as post-COVI…

‘Itty bitty’ falloposcope imaging device used inside fallopian tubes for the first time

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope. [Photo courtesy of the University of Arizona]After years of development, University of Arizona researchers have captured their first images inside fallopian tubes with a new device that could be used to search for early signs of ovarian cancer before it spreads.

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope, which has a diameter of only 0.8 mm.

“It’s itty bitty,” she said in a news release. “You just couldn’t have fabricated something like this, even six, seven years ago.”

Get the full story at our sister site, Medical Design & Outsourcing.

‘Itty bitty’ falloposcope imaging device used inside fallopian tubes for the first time

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope. [Photo courtesy of the University of Arizona]

After years of development, University of Arizona researchers have captured their first images inside fallopian tubes with a new device that could be used to search for early signs of ovarian cancer before it spreads.

University of Arizona BIO5 Institute Director Jennifer Barton developed the high-resolution falloposcope, which has a diameter of only 0.8 mm.

“It’s itty bitty,” she said in a news release. “You just couldn’t have fabricated something like this, even six, seven years ago.”

Dr. John Heusinkveld has used the falloposcope since September to look inside the fallopian tubes of four volunteers who were having their tubes removed for non-cancer reasons.

“This is the first endoscope that can fi…

Zimmer Biomet’s chief accounting officer is leaving for a new job

Carrie Nichol [Photo courtesy of Zimmer Biomet]Chief Accounting Officer Carrie Nichol is leaving Zimmer Biomet (NYSE:ZBH) effective Nov. 26, the Warsaw, Indiana-based medical device company said on Friday.

Nichol also serves as VP, controller and principal accounting officer. She joined Zimmer Biomet in September 2019 from pharma giant Endo International, where she was SVP, controller and chief accounting officer.

Get the full story on our sister site, Medical Design & Outsourcing.

Zimmer Biomet’s chief accounting officer is leaving for a new job

Carrie Nichol [Photo courtesy of Zimmer Biomet]

Chief Accounting Officer Carrie Nichol is leaving Zimmer Biomet (NYSE:ZBH) effective Nov. 26, the Warsaw, Indiana-based medical device company said on Friday.

Nichol also serves as VP, controller and principal accounting officer. She joined Zimmer Biomet in September 2019 from pharma giant Endo International, where she was SVP, controller and chief accounting officer.

“Nichol is pursuing another employment opportunity and her departure is not the result of any disagreement regarding the company’s financial reporting or accounting policies, procedures, estimates or judgments,” Zimmer Biomet said in a filing with the U.S. Securities and Exchange Commission.

Derek Davis will serve as principal accounting officer and interim controller and chief accounting officer while the company searches for Nichol’s replacement. Davis previously ser…

Diversity in medtech: Just 21% of executive roles are held by women

The prevalence of women in corporate leadership positions within the medical device industry remains low, and the rate of increase is stagnant despite new initiatives to increase diversity in the industry.

Just 21% of top executives at the world’s 100 world’s biggest medical device companies are women, according to an analysis of Medical Design & Outsourcing‘s annual Big 100 breakdown of the top revenue-generating medical device companies in the world.

The analysis involved seeing who shows up on the leadership pages on the corporations’ websites. While the overall number of women executives on such pages is up 1 percentage point from 2020, the average percentage of women in medtech companies’ top executive ranks remained unchanged from last year at 19%.

“The medtech workforce must mirror the patients we serve if we are going to succeed in delivering innovative technology to populations who need it,” AdvaMed chief financial officer and chief operatin…

Diversity in medtech: Just 21% of executive roles are held by women

The prevalence of women in corporate leadership positions within the medical device industry remains low, and the rate of increase is stagnant despite new initiatives to increase diversity in the industry.

Just 21% of top executives at the world’s 100 world’s biggest medical device companies are women, according to an analysis of Medical Design & Outsourcing‘s annual Big 100 breakdown of the top revenue-generating medical device companies in the world.

The analysis involved seeing who shows up on the leadership pages on the corporations’ websites. While the overall number of women executives on such pages is up 1 percentage point from 2020, the average percentage of women in medtech companies’ top executive ranks remained unchanged from last year at 19%.

“The medtech workforce must mirror the patients we serve if we are going to succeed in delivering innovative technology to populations who need it,” AdvaMed chief financial officer and ch…

Women researchers receive a fraction of funding from the world’s biggest medtech companies

The gender divide in medtech extends beyond leadership and into funding for investigational studies by U.S. physicians.

Only 6.7% of physicians who received research payments from the world’s largest medical device companies in 2020 were women, according to an analysis of Medical Design & Outsourcing’s Big 100 list of medtech companies and CMS Open Payments data.

Among the 20 medical device companies that fund research by U.S. physicians are 3M, Abbott, BD, Boston Scientific, Johnson & Johnson (dba J&J Surgical Vision and J&J Vision Care), Medtronic (dba Medtronic, Medtronic Minimed, Medtronic USA, Medtronic Vascular), Royal Philips (dba Philips Electronics), Stryker and Zimmer Biomet.

Together, those companies paid $3.9 million to 312 doctors in 2020, but only 21 were women, receiving a collective $402,600.

Women physicians, on average, received 15.7% of payments from each of the top medtech companies, but accounted f…